Top 20 IPOs in Healthcare by Total Fund Value
PharmaShots
JANUARY 31, 2023
Shots: Immutable capital demands and high-spending drug development plans are the most common drivers in encouraging fully-fledged private healthcare companies to go public. The lead program of the company, THIO, is an investigational dual mechanism of action drug incorporating telomere targeting and immunogenicity in patients with NSCLC.
40 
Let's personalize your content